CVKD

Conviction 0HealthcareScan · Thu, Jun 25, 2026

CVKD$2.90-2.85%

ResistanceSupportVol 14Insider sell

Vol MA14 80.07K

Mar 26Apr 14May 1May 19Jun 8Jun 25

Cadrenal Therapeutics, Inc.PHARMACEUTICAL PREPARATIONSwww.cadrenal.com ↗

Price2.90

Change-2.85%

Gap+6.04%

Rel volume0.43×

Avg volume77.25K

Avg $ vol293.86K

SMA 203.85

SMA 504.84

SMA 2008.25

Price vs 50-40.21%

Price vs 200-64.93%

MA stackbearish

50/200 cross—

Supertrenddown · 4.40

RSI (14)29

MACD hist-0.06

MACD cross—

Stoch %K / %D17 / 15

ADX (14)35

+DI / −DI7 / 26

RSI divergence—

MACD divergence—

ATR %+17.26%

ADR %12.10%

52w high14.20

52w low2.90

From 52w high-79.61%

Above 52w low+0.00%

New 52w highNo

SqueezeOff

Bollinger width68.99%

%B0.14

Donchian pos13.09%

Donchian high5.19

Donchian low2.55

AVWAP (52w high)7.31

vs AVWAP high-60.37%

AVWAP (52w low)2.91

vs AVWAP low-0.67%

OBV trendDown

Chaikin MF (20)-0.40

Today vs 20d0.43×

Avg vol (14d)80.07K

Avg vol (20d)77.25K

Avg $ vol (20d)293.86K

Market cap8.3M

RS 3m (vs SPY)-60.25%

RS 6m (vs SPY)-65.82%

RS line new highNo

Trend template0/8

Technical rank3.1

1 week-6.61%

1 month-44.22%

3 months-46.59%

6 months-61.58%

1 year-74.24%

YTD-60.50%

P/E-0.63

P/B4.62

P/S—

P/FCF-0.66

EPS-6.64

Div yield—

ROE-736.59%

ROA-462.51%

Debt/Eq0.33

Current2.68

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-24.28%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value6.59M

Revenue—

Net income-2.5M

Gross profit—

Free cash flow-12.61M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.87M

Employees5

ListedFri, Jan 20, 2023

Free float1.78M

Float %76.1%

Short interest68.65K

Days to cover1.2d

Short volume84.4%

Squeeze score34 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank3.1 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.58

Support3.58

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CVKD

All disclosures →

No recent disclosed trades by Congress in CVKD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CVKD · 9 sells

Insider	Side	Shares	Value	Traded	Filed
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-23	Sell	2.28K	$7K	2026-06-23	2026-06-24
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-22	Sell	9.17K	$33K	2026-06-22	2026-06-24
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-17	Sell	513	$2K	2026-06-17	2026-06-18
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-16	Sell	3.61K	$11K	2026-06-16	2026-06-18
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-10	Sell	3.5K	$15K	2026-06-10	2026-06-10
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-09	Sell	12.99K	$53K	2026-06-09	2026-06-10
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08	Sell	5.89K	$26K	2026-06-08	2026-06-10
Pham Quang X Chairman, CEO and Interim CFO · Common Stock · 2026-06-08	Other	—	—	2026-06-08	2026-06-10
Pham Quang X CEO and Chairman · Common Stock · 2026-06-05	Sell	2.06K	$9K	2026-06-05	2026-06-05
Pham Quang X CEO and Chairman · Common Stock · 2026-06-04	Sell	3.9K	$17K	2026-06-04	2026-06-05

SEC filings

EDGAR filings in CVKD · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.